Skip to content

About us

eCounsel group

A boutique firm with unparalleled expertise in business and technology. We have good command of industrial ecology and legal practice, and have undertaken highly regarded cases. Because the small business scope, we pay more emphasis on effectiveness and efficiency, and choose clients with deliberation. The managing partner not only has extensive experiences in various legal issues more over than 20 years, but invests and manages several technology companies. In addition, he always checks each case rigorously. Clients’ business objectives are our primary focus. To achieve the same in the most cost-effective fashion trumps all seemingly sophisticated legal discussions.

Healthcare vs. Drug Price

2015 - 12 - 09

Media in Taiwan has been reporting that drug price investigations result in low drug prices and pharmaceutical companies threaten to leave Taiwan.


台灣諸多媒體,一面講因為藥價調查造成健保核價太低、一面說原廠藥要退出台灣,連續不間斷地放送國外藥廠勾結醫師所發表的業配新聞。

他們藉此恐嚇公眾,並灌輸有病也無藥可用的醫療困境。

健保在藥品這個問題上當然有大問題,我們也認為核價這件事情應該有更合理的彈性。但是,大家是否清楚,在台灣,醫師開處方箋過度浮濫(順應病人要求)、病人的部分負擔太輕(上限NT$200)、各醫療院所為相同病人開立重複藥物、病人持處方箋取藥後未服用而廢棄之比例過高等的情事,已經造成台灣健保藥費在健保總支出上占有25%的比例。

我們再看看這篇WSJ報導:

Specialty medications for ills such as cancer and multiple sclerosis are so pricey that despite making up only about 1% of prescription volume at the University of Minnesota, they account for 28% of its drug costs, said Kenneth Horstman, director of benefits and compensation. Pharmacy costs are about 17% of its health plan’s spending, up from less than 14% in 2013

明尼蘇達大學給其現任及退休教職員與家屬(約39,000人)的醫療保險中,支付癌症和多發性硬化症的藥,雖然僅占處方箋的1%,但卻拿走了28%的藥費。2013年,藥費占全部醫療開支的14%,到2014已經到了17%,而17%,已讓老美陷入困境。

Another increasingly common strategy is “step therapy,” which requires that patients to be treated with lower-cost drugs before the health plan will pay for a more expensive option. This year, about 69% of employers had step-therapy rules, compared with 56% in 2011…

藥價年成長幅度近10%,高於其他醫療支出之成長幅度一倍。因此,愈來愈多的美國醫保方案,要求採用漸進式治療,也就是只准醫生處方箋上先開低價藥(否則不准核銷),如果無效才能再開較貴的藥品。2011年時只有56%的雇主採用這種模式的醫保,今年,升到69%。http://www.wsj.com/articles/employers-battle-drug-costs-1450488416

當然,還有其他措施,比方說提高病人必須自付的藥費的部分負擔。明尼蘇達大學已將最高上限調到了USD75,等於台幣$2,400,是台灣健保藥費部分負擔的12倍。

藥價與醫療保險政策,不是僅需搞定藥廠金援就可輕易解套。

Recommended article 

The Compliance of a Product Launch - The Controversial Case of Uber

The nature of law is a powerful type of value judgments. The way we make laws has a lot to do with our history, culture, ethics, customs, race, and forms of government, etc. Continue reading

Music Streaming Services vs. Copyright Holders

PUNCHLINE is a aspiring new media in Taiwan. But every time when it weighs in on digital media, its arguments can barely scratch the surface of the reality. Continue reading

Internal Controls and Compliance Regulations in Taiwan

In Taiwan, Criteria for Establishment of Internal Control Systems by Public Companies is the most significant regulation regarding internal controls. 在台灣,最主要的內部控制規範是「公開發行公司建立內部控制制度處理準則」,本準則是依據證券交易法的規定授權,而由前主管機關「財政部證券暨期貨管理委員會」(現已改為行政院金融監督管理委員會)於民國91年11月18日所發布的,目前最新的條文則是於民國96年7月17日修正過後的版本。 由於COSO報告與美國的沙賓法案對於全世界的影響力極為廣大深遠,我國當然也不可能置身事外而不受到美國的影響,大致上,我國內控處理準則的三大目標與五大要素都是符合COSO報告所提出的架構,為了因應許多企業弊案而生的沙賓法案也是我國規範的最佳參考對象。 我國的內控處理準則並非如大陸一樣是以上市公司為施行對象,而是範圍稍微廣一點的公開發行公司1,而依據該處理準則的定義,內部控制是指:「由經理人所設計,經董事會所通過,並由董事會、經理人及其他員工執行之管理過程,其目的在於促進公司的健全經營,以合理確保下列目標之達成:一、營運之效果及效率。二、財務報導之可靠性。三、相關法令之遵循。」COSO報告的影響力可見一斑。 雖然美、中、台的內部控制制度應是系出同源,下我們仍然想要從我國的內控處理準則裡面找出一些蛛絲馬跡,看看在一些重要的制度方面,台灣是否跟得上世界潮流? 參考資料: 1. 首次辦理公開發行之公司必須建立有效的內部控制制度,並經會計師審查認為無重大缺失後才能申請公開發行。